IP Library Granted Patent US 7,691,823
Granted Patent B2
US 7,691,823 · App. 11/075,646 · Granted Apr 6, 2010

RIP140 regulation of glucose transport

Assignee: University of Massachusetts
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,691,823
App. No.
11/075,646
Granted
Apr 6, 2010
Kind
B2
Abstract

Inhibition of RIP140 increases glucose transport. Compounds that inhibit RIP140 expression or activity are useful for treating disorders associated with aberrant glucose transport (e.g., diabetes), treating obesity, increasing metabolism (e.g., fatty acid metabolism), and increasing brown fat.

Claims (6)

1. A method for increasing glucose transport in a cell in vitro, the method comprising:

providing a cell in vitro; and

contacting the cell with a small inhibitory RNA (siRNA) that inhibits expression of a RIP140 polypeptide, thereby increasing glucose transport in the cell.

2. The method of claim 1 , wherein the siRNA comprises a sequence selected from SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, and SEQ ID NO:4.

3. The method of claim 1 , wherein the siRNA inhibits RIP140-mediated suppression of expression of a gene.

4. The method of claim 1 , wherein the cell is an adipocyte.

Assignments (2)
CONFIRMATORY LICENSE Recorded Apr 6, 2017
From: UNIVERSITY OF MASSACHUSETTS MEDICAL SCH
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 042170/0938 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 30, 2005
From: CZECH, MICHAEL P.; POWELKA, AIMEE; GUILHERME, ADILSON L.; CHERNIACK, ANDREW D.
To: UNIVERSITY OF MASSACHUSETTS
Reel/Frame 016461/0513 →
Continuity (2)
Provisional Application 6055067700 · Mar 5, 2004
Related Publication 20050261223A1 · Nov 24, 2005